<p>Meta-analysis of 5-year overall survival between CD133(+) and CD133(−) gastric cancer patients.</p
<p>Meta-analysis of 0.5-year, 1-year, and 2-year survival probability for S-1-based chemotherapy com...
Copyright © 2014 Ju-gang Wu et al. This is an open access article distributed under the Creative Com...
<p>HR, hazard ratio; CI, confidence interval;</p>a<p>Numbers of cases in each group; * Statistically...
<p>Meta-analysis of overall survival between CD133 positive and CD133 negative in NSCLC patients.</p
<p>Meta-analysis of disease free survival between CD133 positive and CD133 negative in NSCLC patient...
Objective: To investigate the influence of CD133+ expression on patients' survival and resistance of...
(A) Survival of gastric cancer patients with CD63 expression in cancer cells. The Kaplan–Meier survi...
To investigate the correlation between CD133-positive gastric cancer and clinicopathological feature...
To investigate the correlation between CD133-positive gastric cancer and clinicopathological feature...
<p>Meta-analysis of correlation between CD133 expression and lymph node metastasis in NSCLC patients...
<p>NS, number of studies, NP, number of patients; OR, odd ratio; RR, risk ratio; CI, confidence inte...
<p>Meta-analysis of correlation between CD133 expression and differentiation in NSCLC patients.</p
AbstractObjectiveTo investigate the influence of CD133+ expression on patients' survival and resista...
<p>Univariate and multivariate survival analysis of clinic-pathologic variables in 1343 cases of gas...
<p>Multivariate survival analysis of 299 gastric cancer patients with positive node metastasis (acco...
<p>Meta-analysis of 0.5-year, 1-year, and 2-year survival probability for S-1-based chemotherapy com...
Copyright © 2014 Ju-gang Wu et al. This is an open access article distributed under the Creative Com...
<p>HR, hazard ratio; CI, confidence interval;</p>a<p>Numbers of cases in each group; * Statistically...
<p>Meta-analysis of overall survival between CD133 positive and CD133 negative in NSCLC patients.</p
<p>Meta-analysis of disease free survival between CD133 positive and CD133 negative in NSCLC patient...
Objective: To investigate the influence of CD133+ expression on patients' survival and resistance of...
(A) Survival of gastric cancer patients with CD63 expression in cancer cells. The Kaplan–Meier survi...
To investigate the correlation between CD133-positive gastric cancer and clinicopathological feature...
To investigate the correlation between CD133-positive gastric cancer and clinicopathological feature...
<p>Meta-analysis of correlation between CD133 expression and lymph node metastasis in NSCLC patients...
<p>NS, number of studies, NP, number of patients; OR, odd ratio; RR, risk ratio; CI, confidence inte...
<p>Meta-analysis of correlation between CD133 expression and differentiation in NSCLC patients.</p
AbstractObjectiveTo investigate the influence of CD133+ expression on patients' survival and resista...
<p>Univariate and multivariate survival analysis of clinic-pathologic variables in 1343 cases of gas...
<p>Multivariate survival analysis of 299 gastric cancer patients with positive node metastasis (acco...
<p>Meta-analysis of 0.5-year, 1-year, and 2-year survival probability for S-1-based chemotherapy com...
Copyright © 2014 Ju-gang Wu et al. This is an open access article distributed under the Creative Com...
<p>HR, hazard ratio; CI, confidence interval;</p>a<p>Numbers of cases in each group; * Statistically...
DOI
Add to ORKG